TrialJournal of the American Society of Nephrology : JASN2026

Baseline Kidney Function, Albuminuria, and Urine Albumin-Creatinine Ratio Reduction with Finerenone, Empagliflozin, or Both: Post Hoc Analyses of CONFIDENCE Trial.

Amy Mottl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.